Synthesis and antitumor activity of novel pyrimidinyl pyrazole derivatives

Chemical and Pharmaceutical Bulletin

Volumn 47, Issue 12, 1999, Pages 1679-1684

  Naito, Hiroyuki ^a   Sugimori, Masamichi ^a   Mitsui, Ikuo ^a   Nakamura, Yoshihide ^b   Iwahana, Michio ^a   Ishii, Mineko ^a   Hirotani, Kenji ^a   Kumazawa, Eiji ^a   Ejima, Akio ^a  

^a DAIICHI SANKYO CO   (Japan)

^b FUJI CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

Antitumor activity; Cytotoxic activity; Pyrazole

Indexed keywords

GLYCOPROTEIN P; PROPYLENE; PYRAZOLOPYRIMIDINE DERIVATIVE; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES; CANCER INHIBITION; CYTOTOXICITY; DRUG MECHANISM; DRUG SYNTHESIS; FIBROSARCOMA; HUMAN; HUMAN CELL; LEUKEMIA P 388; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

EID: 0033401285     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.47.1679     Document Type: Article

References (9)

1. Ueno K., Moroi R., Kojima H., Chiba T., Japan Kokai Tokkyo Koho, JP 74 11705 (1974) [Chem. Abstr., 81, 91517k (1974)].
2. Ueno K.,Ohmura Y., Moroi R., Akashi A., Arimoto M., Kasahara A., Ger. Patent, DE 2038503 [Chem. Abstr., 75, 4912c (1971)].
3. Sato M., Arimoto M., Ueno K., Kojima H., Yamasaki T., Sakurai T., Kasahara A., J. Med. Chem., 21, 1116-1120 (1978).
4. a) Lehnert M., European J. Cancer. 32A, 912-920 (1996);
5. b) Colin de Verdiere A., Dubernet C., Nemati F., Poupon M. F., Puisieux F., Couvreur P., Cancer Chemother. Pharmacol., 33, 504-508 (1994).
6. Mitsui I., Kumazawa E., Hirota Y., Aonuma M., Sugimori M., Ohsuki S., Uoto K., Ejima A., Terasawa H., Sato K., Jpn. J. Cancer Res., 86, 776-782 (1995).
7. Kiura K., Ohnoshi T., Tabata M., Shibayama T., Kimura I., Acta Med. Okayama, 47, 191-197 (1993).
8. Asper H., Baggiolini M., Burki H. R., Lauener H., Ruch W., Stille G., European J. Pharmacol., 22, 287-294 (1973).
9. Tachizawa H., Sudo K., Sano M., European J. Pharmacol., 59, 245-251 (1979).